THU-382 Lead-in cohort results from a phase 2 study of a novel 8-week combination regimen of Bemnifosbuvir and Ruzasvir in patients with chronic hepatitis C virus infection

Saved in:
Bibliographic Details
Published in:Journal of hepatology 2024-06, Vol.80, p.S819-S819
Main Authors: Jucov, Alina, Conway, Brian, Iliescu, Laura, Mitrut, Paul, Florescu, Simin, Cernat, Roxana, Ermacicova, Elena, Lynch, Shannan, Majarian, Marina, Izmailyan, Sergey, Zhou, Xiao-Jian, Pietropaolo, Keith, Belanger, Bruce, Horga, Arantxa, Hammond, Janet
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0168-8278
1600-0641
DOI:10.1016/S0168-8278(24)02257-8